James Barlow, MD
MOHS-Micrographic Surgery · Surprise, AZNPI 1982683405
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $136 and has fallen 75.1% since, to $34 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in AZ, where the typical reported total is $1,522.
Across 21 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$90
- Sun Pharmaceutical Industries Inc.$57
- Acelrx Pharmaceuticals, Inc.$48
- Galderma Laboratories, L.p.$45
- Sanofi$30
- Boston Scientific$27
- plus $134 from 7 others
What the payments were for
- Food & beverage$430100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$430 in reported general payments places this provider in the 15th percentile of 38 mohs-micrographic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 85 | $6,409 |
| Doxycycline Hyclate | 80 | $1,232 |
| Clobetasol Propionate | 42 | $1,192 |
| Cephalexin | 148 | $827 |
| ValacyclovirValacyclovir Hcl | 34 | $654 |
| Metronidazole | 11 | $508 |
| Ketoconazole | 25 | $414 |
| Triamcinolone Acetonide | 22 | $326 |
| Hydrocortisone | 30 | $146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $141 |
| Spironolactone | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Surprise
- Betty Hinderks DavisSurprise$2K
- Lynn JuracekSurprise$309
- John EbnerPhoenix$26K
- Joseph JanikChandler$8K
- J Ryan JacksonMesa$6K
- Seth GoodmanSun City$6K
- Mitchell ManwayScottsdale$6K
- Amena DelucaPhoenix$6K
- Tejaswi MudigondaLake Havasu City$5K
- Christopher WeyerSierra Vista$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.